Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Library Archives
Volume 25, 2021 Archive

Six issues from 2021 in one convenient archive.

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Issue/Volume Title
January/February 2021
Vol. 25 No. 1
Volume 25, Number 1
March/April 2021
Vol. 25 No. 2
Volume 25, Number 2
May/June 2021
Vol. 25 No. 3
Volume 25, Number 3
July/August 2021
Vol. 25 No. 4
Volume 25, Number 4
September/October 2021
Vol. 25 No. 5
Volume 25, Number 5
November/December 2021
Vol. 25 No. 6
Volume 25, Number 6

Volume 25, 2021 Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: The NASEM cBHT Report, Part 2
Allen Loyd V Jr
Jan/Feb 2021
Pg. 4

Cleanroom Cleanliness
Mulder Kyle
Jan/Feb 2021
Pg. 6-12

Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 2
DeRosa Angela
Jan/Feb 2021
Pg. 14-17

Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
McKettrick Greg
, Yoch Doug
Jan/Feb 2021
Pg. 18-23

Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
McElhiney Linda F
Jan/Feb 2021
Pg. 24-28

Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Allen Loyd V Jr
Jan/Feb 2021
Pg. 31-38

Calculations
Stockton Shelly J
Jan/Feb 2021
Pg. 40

Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2021
Pg. 42

Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 43

Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 44

Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 45

Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2021
Pg. 46

Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 47

Design and Performance of an Inexpensive Water Activity Meter
Gilda Sagar S
, Schober Joseph M, McPherson Timothy
Jan/Feb 2021
Pg. 48-51

Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan
, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021
Pg. 52-61

Formulation and Pharmaceutical Evaluation of Extemporaneous α-arbutin Creams for the Treatment of Melasma
Teeranachaideekul Veerawat
, Boonsongsawat Worrawee, Asanawittaya Waralee, Jintapattanakit Anchalee, Chantasart Doungdaw, Wongrakpanich Amaraporn
Jan/Feb 2021
Pg. 62-72

Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Patel Gopesh
, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
Jan/Feb 2021
Pg. 73-81

Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets
Cheung Matthew
, Zhao Fang, Dave Vivek S
Jan/Feb 2021
Pg. 82-87

PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
Mar/Apr 2021
Pg. 92

The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
McKettrick Greg
, Yoch Doug
Mar/Apr 2021
Pg. 94-98

Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing
Riepl Mike
Mar/Apr 2021
Pg. 100-103

Experimental Multidisciplinary Approach Based on Compounded Capsule's Quality Evaluation for Pharmacy Undergraduate Courses
dos Santos Matheus Skrcek Ribeiro
, de Lima Amanda Muniz dos Santos, Christoff Adriana de Oliveira, Teixeira Mariana Lopes, Carneiro Jaqueline
Mar/Apr 2021
Pg. 104-108

Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic
Roberts Patricia A
, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
Mar/Apr 2021
Pg. 109-113

Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
Mar/Apr 2021
Pg. 115-124

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants
Allen Loyd V Jr
Mar/Apr 2021
Pg. 126-128

Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139

Calculations
Stockton Shelly J
, Bui Phi H
Mar/Apr 2021
Pg. 140-141

Amlodipine 1-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 142

Canine Soft Chew Base (Veterinary)
Allen Loyd V Jr
Mar/Apr 2021
Pg. 143

Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 144

Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2021
Pg. 145

In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Kohan Hamed Gilzad
, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Mar/Apr 2021
Pg. 146-155

Stability of Fagron's Phytobase Cream Compounded with Various Hormones
Wynn Tom
, Taylor Sarah, Zander Clark
Mar/Apr 2021
Pg. 156-162

Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes
Walsh Andrea
, Ziegler Blake, Lingertat-Walsh Karen, Law Shirley, Walker Scott E
Mar/Apr 2021
Pg. 163-168

Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
Mar/Apr 2021
Pg. 169-175

PreScription: The Ethical Pharmacist
Allen Loyd V Jr
May/Jun 2021
Pg. 180

Pharmacy Technicians' Perceptions of Risk Reduction Strategies Implemented in Response to the Repetitive Strain Injury Associated with Sterile Compounding
Zamani Mazdak
, Chan Kayin, Wilcox Julie
May/Jun 2021
Pg. 182-186

Insurance Considerations for the Pharmacy Professional
Jones Kirsten
May/Jun 2021
Pg. 190-195

A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies
Hall Essence
, Levesque Dan, Rashid Mamoon, Mullins Randy, Hossain Mohammad Faisal
May/Jun 2021
Pg. 197-204

FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows
Brunner Scott
May/Jun 2021
Pg. 206-209

Quality Control: Testing for "Micromonsters": Viable Air and Surface Sampling in Aseptic Compounding
Mulder Kyle
May/Jun 2021
Pg. 211-216

Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents
Allen Loyd V Jr
May/Jun 2021
Pg. 218-221

Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
May/Jun 2021
Pg. 222-229

Calculations
Stockton Shelly J
May/Jun 2021
Pg. 230-231

Levofloxacin 50-mg/mL in Ora-Plus and Strawberry Syrup Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 232

Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 233

Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 234

Temozolomide 10 mg/mL in Oral Mix SF Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 235

Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design
Lupatini Rodrigo
, Sidhu Raman, Patel Harshad, Bichar Katia
May/Jun 2021
Pg. 236-240

In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester
McKinney Rachael D
, Dunbar Jacob R
May/Jun 2021
Pg. 241-245

Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Hui Ada
, Yin Jian, Liu Wei, Zheng Kai
May/Jun 2021
Pg. 246-257

Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation
Odanaka Keita
, Kojima Hiroki, Nakagawa Naoto
May/Jun 2021
Pg. 258-262

PreScription: Endemics, Epidemics, and Pandemics
Allen Loyd V Jr
Jul/Aug 2021
Pg. 268

Growing a Compounding Practice: Successful Marketing to Underserved Populations
McKettrick Greg
, Yoch Doug
Jul/Aug 2021
Pg. 270-274

Expecting the Expected: Planning Considerations for Cleanroom Construction
Roberts Patricia A
, Kroon Laura
Jul/Aug 2021
Pg. 276-281

Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2
Riepl Mike
Jul/Aug 2021
Pg. 282-287

Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists
Kiselova Olga
, Maurina Baiba, Sidlovska Venta
Jul/Aug 2021
Pg. 288-295

A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot
Brunner Scott
Jul/Aug 2021
Pg. 296-297

Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1
Higgins Doral (Neal) O
, Prudom Melanie J, Summers Amy
Jul/Aug 2021
Pg. 298-302

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases
Allen Loyd V Jr
Jul/Aug 2021
Pg. 304-309

Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
Jul/Aug 2021
Pg. 311-317

Calculations
Stockton Shelly J
Jul/Aug 2021
Pg. 318

Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube
Allen Loyd V Jr
Jul/Aug 2021
Pg. 320

Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 321

BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel)
Allen Loyd V Jr
Jul/Aug 2021
Pg. 322

Budesonide 0.0.25% Mucoadhesive Gel
Allen Loyd V Jr
Jul/Aug 2021
Pg. 323

Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2021
Pg. 324

Hydrocortisone 2-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 325

Moh's Paste, Modified
Allen Loyd V Jr
Jul/Aug 2021
Pg. 326

Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored
Allen Loyd V Jr
Jul/Aug 2021
Pg. 327

Tacrolimus 0.1% Topical Microemulsion
Allen Loyd V Jr
Jul/Aug 2021
Pg. 328

Valsartan 4-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2021
Pg. 329

Stability of Dexmedetomidine in Polyvinyl Chloride Bags Containing 0.9% Sodium Chloride Intended for Subcutaneous Infusions
Wolfe Amanda
, Zhang Jeremy, Lapenskie Julie, Downar James, Kanji Salmaan
Jul/Aug 2021
Pg. 330-335

Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base
Polonini Hudson C
, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
Jul/Aug 2021
Pg. 336-343

Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases
Teimouri Arezou
, Yeung Pollen, Agu Remigius U
Jul/Aug 2021
Pg. 344-351

PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
Sep/Oct 2021
Pg. 356

Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
Sep/Oct 2021
Pg. 358-362

Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth
, Zhao Fang, Schweighardt Anne
Sep/Oct 2021
Pg. 364-371

Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
Sep/Oct 2021
Pg. 372-377

Realities of Pharmaceutical Compounding in the Republic of Uzbekistan
Umarov Ulugbek
, Zdoryk Oleksandr, Kolisnyk Sergii, Fatkhullaeva Muyussar
Sep/Oct 2021
Pg. 378-384

It's Time for a New Philosophy
Brunner Scott
Sep/Oct 2021
Pg. 386-387

Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2
Higgins Doral (Neal) O
, Prudom Melanie J, Summers Amy
Sep/Oct 2021
Pg. 389-395

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Allen Loyd V Jr
Sep/Oct 2021
Pg. 396-400

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes
Allen Loyd V Jr
Sep/Oct 2021
Pg. 403-408

Calculations
Stockton Shelly J
Sep/Oct 2021
Pg. 410

Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 412

Cilazapril 1-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 413

Clonidine 0.01-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 414

Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 415

Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 416

Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 417

Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 418

Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 419

Sorafenib 20-mg/mL in Oil Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 420

Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 421

Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Polonini Hudson
, de Oliveira Ferreira Anderson, Dijkers Eli
Sep/Oct 2021
Pg. 422-426

Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base
Lopalco Antonio
, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Sep/Oct 2021
Pg. 427-430

Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Sep/Oct 2021
Pg. 431-439

PreScription: IJPC -- Twenty-Five Year Anniversary
Allen Loyd V Jr
Nov/Dec 2021
Pg. 444

Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021
Hecq Jean-Daniel
, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
Nov/Dec 2021
Pg. 446-462

Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports
Agbi Kelechi E
, Carvalho Maria, Vieira-Banov Fabiana
Nov/Dec 2021
Pg. 464-467

Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin
Riepl Mike
Nov/Dec 2021
Pg. 468-472

Hospital Compounding in Nigeria: A Review of Needs, Practice, and Suggestions for Pharmaceutical Dispensing Ciurriculum Development
Orubu Ebiowei Samuel F
, Patani Bernard Opatimidi, Arhewoh Matthew Ikhuoria
Nov/Dec 2021
Pg. 475-481

Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars
Harris Kylie
, Wright Edward
Nov/Dec 2021
Pg. 482-485

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 12: Sorbents (Adsorbents and Absorbents)
Allen Loyd V Jr
Nov/Dec 2021
Pg. 486-489

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496

Calculations
Stockton Shelly J
Nov/Dec 2021
Pg. 498

Domperidone 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2021
Pg. 500

Kayexalate in Lactulose
Allen Loyd V Jr
Nov/Dec 2021
Pg. 501

Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 502

Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 503

Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Allen Loyd V Jr
Nov/Dec 2021
Pg. 504

Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 505

Quetiapine Fumarate 10 mg/mL in Ora-Blend
Allen Loyd V Jr
Nov/Dec 2021
Pg. 506

Shari's Burn Cream
Allen Loyd V Jr
Nov/Dec 2021
Pg. 507

Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2021
Pg. 508

Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 509

Compounding Robots for Intravenous Therapy in European Countries: A Review in 2020
Hecq Jean-Daniel
, Soumoy Laura
Nov/Dec 2021
Pg. 510-514

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Nov/Dec 2021
Pg. 515-522

Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution
Zaid Abdel-Naser
, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
Nov/Dec 2021
Pg. 523-527

Return to Top